Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03728972
Brief Title: Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

First Submitted : November 1, 2018
First Submitted that Met QC Criteria : November 1, 2018
First Posted : November 2, 2018

Last Update Submitted that Met QC Criteria : May 12, 2021
Last Update Posted : May 13, 2021